OrbiMed’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,028,354
| Closed | -$30.5M | – | 153 |
|
|
2018
Q3 | $30.5M | Sell |
3,028,354
-483,190
| -14% | -$4.87M | 0.37% | 70 |
|
|
2018
Q2 | $25.4M | Hold |
3,511,544
| – | – | 0.3% | 72 |
|
|
2018
Q1 | $21.2M | Sell |
3,511,544
-1,895,300
| -35% | -$11.4M | 0.26% | 79 |
|
|
2017
Q4 | $52M | Sell |
5,406,844
-764,596
| -12% | -$7.36M | 0.66% | 47 |
|
|
2017
Q3 | $54.8M | Hold |
6,171,440
| – | – | 0.52% | 59 |
|
|
2017
Q2 | $78.1M | Buy |
6,171,440
+100,000
| +2% | +$1.27M | 0.82% | 40 |
|
|
2017
Q1 | $63.8M | Hold |
6,071,440
| – | – | 0.72% | 44 |
|
|
2016
Q4 | $55.9M | Buy |
6,071,440
+569,200
| +10% | +$5.24M | 0.71% | 42 |
|
|
2016
Q3 | $64.9M | Buy |
5,502,240
+814,000
| +17% | +$9.6M | 0.74% | 50 |
|
|
2016
Q2 | $60.7M | Buy |
4,688,240
+130,500
| +3% | +$1.69M | 0.63% | 47 |
|
|
2016
Q1 | $72.9M | Buy |
4,557,740
+191,000
| +4% | +$3.05M | 0.77% | 40 |
|
|
2015
Q4 | $125M | Buy |
4,366,740
+284,940
| +7% | +$8.16M | 1.13% | 31 |
|
|
2015
Q3 | $116M | Buy |
4,081,800
+1,458,800
| +56% | +$41.5M | 1.17% | 30 |
|
|
2015
Q2 | $94.2M | Buy |
2,623,000
+136,600
| +5% | +$4.91M | 0.79% | 38 |
|
|
2015
Q1 | $72.3M | Hold |
2,486,400
| – | – | 0.62% | 45 |
|
|
2014
Q4 | $52.4M | Buy |
2,486,400
+1,015,200
| +69% | +$21.4M | 0.5% | 46 |
|
|
2014
Q3 | $28.5M | Buy |
+1,471,200
| New | +$28.5M | 0.3% | 57 |
|